Trial · NCT00424554
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | LYMPHOPENIA | Blood and lymphatic system disorders | Temozolomide | 2 | 34 | 2 |
| other | LYMPHOPENIA | Blood and lymphatic system disorders | No Intervention | 0 | 6 | 0 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | Temozolomide | 0 | 34 | 0 |
| other | THROMBOCYTOPENIA | Blood and lymphatic system disorders | No Intervention | 1 | 6 | 1 |
| other | DIARRHOEA | Gastrointestinal disorders | Temozolomide | 0 | 34 | 0 |
| other | DIARRHOEA | Gastrointestinal disorders | No Intervention | 1 | 6 | 1 |
| other | PAIN | General disorders | Temozolomide | 0 | 34 | 0 |
| other | PAIN | General disorders | No Intervention | 1 | 6 | 1 |
| other | URINARY TRACT INFECTION | Infections and infestations | Temozolomide | 2 | 34 | 2 |
| other | URINARY TRACT INFECTION | Infections and infestations | No Intervention | 1 | 6 | 1 |
| other | POSTOPERATIVE FEVER | Injury, poisoning and procedural complications | Temozolomide | 0 | 34 | 0 |
| other | POSTOPERATIVE FEVER | Injury, poisoning and procedural complications | No Intervention | 1 | 6 | 1 |
| other | ALANINE AMINOTRANSFERASE INCREASED | Investigations | Temozolomide | 0 | 34 | 0 |
| other | ALANINE AMINOTRANSFERASE INCREASED | Investigations | No Intervention | 1 | 6 | 1 |
| other | HYPERGLYCAEMIA | Metabolism and nutrition disorders | Temozolomide | 1 | 34 | 1 |
| other | HYPERGLYCAEMIA | Metabolism and nutrition disorders | No Intervention | 1 | 6 | 1 |
| other | HYPOKALAEMIA | Metabolism and nutrition disorders | Temozolomide | 0 | 34 | 0 |
| other | HYPOKALAEMIA | Metabolism and nutrition disorders | No Intervention | 1 | 6 | 1 |
| other | HYPONATRAEMIA | Metabolism and nutrition disorders | Temozolomide | 0 | 34 | 0 |
| other | HYPONATRAEMIA | Metabolism and nutrition disorders | No Intervention | 1 | 6 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00424554/events